Recombinant DNA Technology Market Is Anticipated To Reach $844.6 Billion By 2025: Grand View Research, Inc.
The global recombinant DNA technology market is expected to
reach USD 844.6 billion by 2025, according to a new report by Grand View
Research, Inc. Success of genetically engineered human insulin in diabetes
treatment has triggered the development of many other recombinant therapeutics
and drugs. This has translated to the huge success of Recombinant DNA (rDNA)
technology. This technology has offered significant prospects for elucidating
the gap between disease and its effective treatment.
Widespread successful application
of this technique in veterinary product development, genetically modified crop
development, bio pesticides & biofuel production, and gene therapy, are
expected to spur the adoption of this technology throughout the forecast
period.
Use of Genetically Modified (GM)
products, such as GM animals, developed using rDNA method are found to be
indispensable to accelerate medical research. Furthermore, more than 3000
scientific studies have been carried out to assess the GM products safety in
context to its impact on human health and environment.
In addition, there is rising need
to improve the recombinant proteins’ production capacity by several folds,
owing to increase in demand for effective therapeutics for disease treatment.
The aforementioned fact pronounces the technological advances in this sector
thus driving growth.
As per Monsanto and other
proponents of GM crops, genetic engineering is one of the fastest and widely
adopted agricultural innovations over the past few years. This, in turn, is
expected bolster the adoption of rDNA technology for non-traditional
applications.
Germany recombinant DNA technology market, by medical
product, 2014 - 2025 (USD Billion)
Browse full research report on Recombinant DNA Technology Market: http://www.grandviewresearch.com/industry-analysis/recombinant-dna-technology-market
Further key findings from
the report suggest:
- Medical rDNA
products dominated the share in 2016 in terms of revenue generation
- This can be
attributed to the commercial success of insulin which has prompted firms
for further development of recombinant drugs
- Owing to
efficient transient and stable expression capabilities, mammalian
expression system captured the largest share
- This share is
also supported by the improvements in media for high yield using mammalian
expression system
- Health &
disease accounted with the largest share in revenue
- Gene therapy,
antibodies production, drug metabolism investigation, recombinant
therapeutic & vaccine development are recognized as major applications
of this technology in human healthcare management
- Various end-use
segments served by this market encompass pharmaceutical & biotech
entities, academic & research institutes, and other industrial
entities
- End-use wise,
pharmaceutical and biotechnology firms are estimated to be the largest
segment owing to the presence of substantial number of biopharma entities
that have adopted rDNA products
- North America
held the largest share owing to the presence of effective regulations
pertaining to the approval of recombinant therapeutics as well as GM
products
- Asia Pacific
is expected to emerge as the fastest growing regional market
- Conducting
clinical trials in Asian countries such as India is relatively less
expensive compared to western countries. This has resulted into migration
of several global biopharmaceutical developers towards this region
- Biogen; Amgen
Inc., Eli Lilly and Company, Monsanto Company, Novartis AG, and F.
Hoffmann-La Roche Ltd are some of the major companies operating in this
space
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-recombinant-dna-technology-market
About Grand View Research,
Inc:
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment